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Open access under CC BIn label-free biomolecular interaction analysis, a standard injection provides an injection of uniform ana-
lyte concentration. An alternative approach exploiting Taylor dispersion produces a continuous analyte
titration allowing a full analyte dose response to be recorded in a single injection. The enhanced biophys-
ical characterization that is possible with this new technique is demonstrated using a commercially avail-
able surface plasmon resonance-based biosensor. A kinetic interaction model was ﬁtted locally to Taylor
dispersion curves for estimation of the analyte diffusion coefﬁcient in addition to afﬁnity/kinetic con-
stants. Statistical conﬁdence in the measured parameters from a single Taylor dispersion injection was
comparable to that obtained for global analysis of multiple standard injections. The afﬁnity constants
for multisite interactions were resolved with acceptable conﬁdence limits. Importantly, a single analyte
injection could be treated as a high-resolution real-time afﬁnity isotherm and was demonstrated using
the complex two-site interaction of warfarin with human serum albumin. In all three model interactions
tested, the kinetic/afﬁnity constants compared favorably with those obtained from standard kinetic anal-
ysis and the estimates of analyte diffusion coefﬁcients were in good agreement with the expected values.
 2011 Elsevier Inc. Open access under CC BY-NC-ND license.The majority of published kinetic analyses in label-free biosen-
sing have relied on ﬁtting a 1:1 pseudo-ﬁrst-order interaction
model to a series of overlaid binding response curves recorded
from ﬁxed concentration injections (FCIs).1,2 Resolution of multi-
site binding by FCIs is challenging because it is mathematically dif-
ﬁcult to resolve the sum of two superimposed decaying
exponentials [1,2]. For example, in fragment screening, many com-
pounds exhibit nonspeciﬁc binding [3,4] that greatly exceeds the
speciﬁc binding response where both binding components overlap
in time. However, an afﬁnity isotherm can overcome this superim-
position of binding components by providing an analyte titration.
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Y-NC-ND license.concentrations over the ligand-coated surface where the contact
time for each concentration is sufﬁcient to reach equilibrium. A
multisite afﬁnity model is ﬁtted, providing estimates of the afﬁnity
constant for the speciﬁc binding site [5,6]. The run time for higher
afﬁnity interactions is often prohibitive because each injection may
require in excess of 1 h to reach equilibrium. Therefore, the in-
creased resolving power of the technique must be balanced against
the increased run time. For example, in fragment screening, the
number of analyte concentrations required to deﬁne the isotherm
is often reduced to six or less. Although a less deﬁned isotherm
provides less reliable afﬁnity analysis, the results have proven to
be adequate in many cases [7]. The resolving power of this stea-
dy-state method is a consequence of titrating the analyte, and it
was envisaged that a rapid means of performing an analyte titra-
tion would provide similar advantages but without sacriﬁcing res-
olution and/or throughput. We introduce Taylor dispersion
injection (TDi) to generate a continuous analyte titration that is
suitable for both steady-state and kinetic analyses. Using simple
expressions the analyte titration was deﬁned as a function of injec-
tion time and substitution into the appropriate binding interaction
model enabled direct ﬁtting to the TDi binding response curves. We
demonstrate the TDi-based assay format using the following model
interactions: scFv binding receptor, furosemide binding carbonic
anhydrase II, and ﬁnally warfarin binding human serum albumin
(HSA).
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Taylor dispersion theory is an absolute method that does not re-
quire empirical calibration [8] and has been well established for
determination of diffusion coefﬁcients [9]. The theory models the
physical dispersion process, thereby accounting for variations in
ﬂow rate, viscosity, temperature, and capillary geometry and obvi-
ating any need for empirical calibration. In practice, TDi is per-
formed in a similar way to standard FCI but with the addition of
a large dead volume upstream of the ﬂow cell. Dispersion theory
accurately models the effect of the dead volume (i.e., capillary
tube) on the analyte concentration when performed in accordance
with a deﬁned set of conditions and limits. Dispersion theory can
be included in an afﬁnity interaction model by substituting disper-
sion terms that specify the analyte concentration as a function of
injection time. The modiﬁed afﬁnity interaction model can then
be ﬁtted to TDi data for estimation of interaction constants.
Brieﬂy, tracer dispersion in a ﬂow-through capillary was ini-
tially described by Taylor [8] and is illustrated in Fig. 1. An initial
sample volume (Vi) containing analyte is injected into a longFig.1. (A) An analyte sample is loaded into a long capillary with a low internal diameter. P
the sensing regions. The mole fraction of analyte (XA) relative to the loaded analyte concen
of sample into the capillary causes the leading analyte front to mix with the buffer occu
proﬁle in the ﬂow cell as the injection progresses. (C) In a second case, the initial sample
thereby causing mixing at both the leading and tailing sample fronts. A Gaussian-shap
maximum relative mole fraction that is signiﬁcantly lower than unity.narrow capillary (Fig. 1A). The analyte concentration is initially
uniform but gradually evolves into a sigmoidal gradient proﬁle
due to the combined action of analyte diffusion and convective
laminar ﬂow (Fig. 1B). Low-molecular-weight molecules diffuse
more rapidly than larger molecules and tend to negate convective
dispersion more effectively, thereby generating a sigmoidal gradi-
ent with increased slope. The analyte enters the ﬂow cell as an
increasing analyte concentration gradient where the inﬂection
point of the sigmoidal proﬁle (SigTDi) deﬁnes the residence time
(s). This residence time can also be deﬁned as the ratio of the cap-
illary volume to the ﬂow rate, assuming that, on average, the ana-
lyte is not retarded relative to the convective ﬂow. Additives (e.g.,
blocking proteins, surfactants) that block nonspeciﬁc binding sites
on the capillary wall are sometimes required to prevent retarda-
tion. Vi should be large enough to exceed s in order to produce a
full sigmoidal dispersion proﬁle. Injecting a small sample volume
(<5% capillary tube volume) into the capillary tube followed by
analyte-free buffer produces a dispersion peak (PulseTDi) due to
dispersion at both tailing and leading sample fronts (Fig. 1C),
where the peak maximum deﬁnes the residence time. In PulseTDi,ressure-driven ﬂow causes the liquid to exit the capillary into a ﬂow cell that houses
tration, Ci, is uniform before migration through the capillary. (B) Continued delivery
pying the capillary. The relative mole fraction in the ﬂow cell assumes a sigmoidal
volume migrates through the capillary on continued supply of analyte-free buffer,
ed analyte gradient forms within the ﬂow cell as the injection progresses, giving a
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ume. The SensíQ Pioneer is a commercially available biosensing
system that incorporates a capillary tube suitable for performing
the TDi assay formats demonstrated in this article.
TDi modeling
Taylor’s analytical solution [8] describing the analyte concen-
tration distribution for PulseTDi is
CðtÞ ¼ 2CinV i
p3=2d2
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where
C(t) = analyte concentration at detector (mol m3);
Cin = concentration of analyte injected (mol m3);
Vi = sample injection volume (m3);
d = tubing diameter (m);
s = mean analyte residence time = L/u (s);
L = length of tube (m);
u = average velocity of ﬂuid (m s1);
k = Taylor–Aris dispersion coefﬁcient (m2 s1);k ¼ a u
2d2
192D
þ D ð2Þ
D = analyte diffusion coefﬁcient (m2 s1);
a = correction factor.
We include a correction factor (a) to compensate for any depar-
tures from theory. In practice all capillary tubes tested returned
a ﬃ 1.0, indicating that Taylor’s theory does provide an absolute
method. Taylor’s solution for SigTDi is given by
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It is possible to compensate for systematic errors such as injection
timing offsets while also verifying dispersion parameters for each
individual injection by analyzing bulk refractive index dispersions.
For example, TDi analysis of a standard bulk refractive index com-
pound, such as sucrose, or analysis of dispersion curves contained
in the reference channel response can be included in each assay.
In many cases, a solvent dispersion is present due to a mismatch
in concentration between the sample buffer and the running buffer
and can serve as an internal standard to verify dispersion parame-
ters before ﬁtting the afﬁnity model. The limit ﬂow rates for a given
capillary and analyte for application of dispersion theory are de-
ﬁned as follows. The Peclet number (NPe) is a dimensionless number
that is useful in deﬁning the lower ﬂow rate limit to be used for a
given analyte with a given capillary [10]:
NPe ¼ ðduÞ=D with limit > 500 ð5Þ
The upper ﬂow rate limit [10] can be deﬁned in terms of dimension-
less time (s0),
where s0 ¼ Ds=ð0:5dÞ2 with limit > 3:0 ð6Þ
The analyte diffusion coefﬁcient can be estimated [11,12] from the
expectedMr of the analyte, allowing calculation of NPe and s0. These
limits can be automatically calculated before running the assay in
order to constrain the experimental conditions within the speciﬁed
limits.Kinetic interaction model
The two-compartment 1:1 pseudo-ﬁrst-order kinetic interac-
tion model is composed of two differential equations that describe
the change in the concentration of afﬁnity complexes (dR/dt) at the
sensing surface and the analyte concentration gradient (dC/dt) as
the analyte passes from the bulk liquid through the diffusion
boundary layer to the sensing surface [13,14]:
dC
dt
¼ ðkaCðRmax  RÞ þ kdRþ kmðCin  CÞÞ ð7ÞdR
dt
¼ kaCðRmax  RÞ  kdR ð8Þ
where R is the biosensor response (response units, RU), Rmax is the
maximum response expected if all ligand sites are occupied (RU),
and Cin is the injected analyte concentration (M), which becomes
zero when the dissociation phase begins. C is the concentration
(M) of the analyte at the sensing surface, km is the mass transport
constant (RU M1 s1), ka is the association rate constant (m1 s1),
and kd is the dissociation rate constant (s1). km can be estimated
accurately from the following equation [15,16] assuming that the
dextran hydrogel does not contribute to mass transport limitation
(MTL):
km ¼ 109Mr1:43 1 L1=L2ð Þ
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where F is the ﬂow rate (m3 s1) and L1 and L2 are the lengths (m) of
the functionalized surface relative to the start and end of the sens-
ing region, respectively. H is the height (m) and W is the width (m)
of the ﬂow cell. The geometry of the ﬂow cell is well deﬁned, allow-
ing these parameters to be held constant. Mr is usually known or,
alternatively, it can be estimated from D [8].
The bulk analyte concentration is the injected analyte concen-
tration (Cin) and is constant during FCI. However, in TDi the analyte
concentration changes as a function of injection time and can be
modeled by substituting the appropriate dispersion term for Cin.
Fitting the above model, therefore, can include ka, kd, Rmax, km,
and D as ﬁtted parameters. In many cases, MTL is negligible, where
Cin = C, and the two-compartment model reduces to the simple ‘‘ra-
pid mixing’’ model. Any interaction model of interest can be simi-
larly modiﬁed; for example, a two-site interaction model can be
chosen where the response recorded by the biosensor, R(t), is given
by the sum of multiple components as
RðtÞ ¼ ABðtÞ þ AB2ðtÞ þ RIanalyteðtÞ þ RIsolventðtÞ ð10Þ
with ﬁtted parameters ka, ka2, kd, kd2, Rmax, Rmax2, D and Dsolvent.
Two additive sets of Eqs. (7) and (8) are needed to deﬁne the
formation of AB plus AB2 where both incorporate a Taylor disper-
sion term. Each noninteracting dispersed species is included only
when present at a high enough concentration to contribute a sig-
niﬁcant bulk refractive index response. However, the analyte can
often be present at very high concentrations, producing a bulk
refractive index term (RIanalyte). RIanalyte will vary in time according
to the analyte dispersion proﬁle and can be modeled by the appro-
priate dispersion Eqs. (1)–(4), where C(t) and Ci are replaced by
RI(t) and RImax, respectively, and where RIanalyte(t) is the bulk ana-
lyte dispersion and RImax is the maximum bulk refractive index re-
sponse of the analyte in the neat sample. The expected bulk
refractive index response for a given concentration of analyte can
be approximated by the relation 100 RU ﬃ 1 mg ml1, but more
accurate estimates have been published [17,18]. Dimethyl sulfox-
ide (DMSO) is sometimes present at slightly different concentra-
tions in the sample buffer relative to the running buffer, forming
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coefﬁcient (Dsolvent).
Real-time isotherm model
An afﬁnity isotherm for a complex interaction composed of
three afﬁnity sites can be expressed as
Req ¼ Rmax1  C=ðKD1 þ CÞ þ Rmax2  C=ðKD2 þ CÞ þ Rmax3
 C=KD3 þ C ð11Þ
The equilibrium response (Req) is the sum of three afﬁnity binding
terms, each deﬁned by independent parameter values for the satu-
ration response (Rmax) and afﬁnity constant (KD) at each binding
site. However, this afﬁnity model cannot be ﬁtted directly to the
real-time TDi isotherm and therefore cannot be used to determine
D. Therefore, we composed an afﬁnity isotherm model that is anal-
ogous to Eq. (11) but where Req was expressed as a function of injec-
tion time, Req(t), allowing the isothermmodel to be ﬁtted directly to
the TDi curve:
ReqðtÞ ¼ Rmax1  CðtÞ=ðKD1 þ CðtÞÞ þ Rmax2  CðtÞ=ðKD2 þ CðtÞÞ
þ Rmax3  CðtÞ=KD3 þ CðtÞ ð12Þ
where C(t) is given by Eqs. (1)–(4). Because this isotherm model is
complex, it is recommended that two or more TDi curves be used
in order to constrain ﬁtted parameters globally for improved
performance.
Materials and methods
Instrument, sensor chips, and chemicals
SensíQ Pioneer, sensor chips, and chemical coupling reagents
were obtained from FLIR/ICx Nomadics (Oklahoma City, OK, USA,
http://www.discoversensiq.com). All analyses were performed at
25 C unless otherwise stated. All other reagents were obtained
from Sigma (St. Louis, MO, USA). The running buffer contained
10 mM Hepes and 150 mM NaCl (pH 7.4) (Hepes-buffered saline,
HBS) with 0.001% Tween 20 (HBS-T) and 3 mM ethylenediamine-
tetraacetic acid (EDTA) (HBS-TE) unless otherwise stated. Five dis-
persion tubes of varying dimensions were evaluated: tube A with
Vt = 509 ll, d = 0.227 mm; tube B with Vt = 500 ll, d = 0.38 mm;
tube C with Vt = 512 ll, d = 0.50 mm; tube D with Vt = 52 ll,
d = 0.25 mm, and tube E with Vt = 120 ll, d = 0.25 mm. Recombi-
nant human epidermal growth factor receptor 2/crystallizable
fragment (rhErbB2/Fc) chimera was purchased from R&D Systems
(Minneapolis, MN, USA), and anti-ErbB2 single chain variable frag-
ment (scFv) was a kind donation by a company that wished to re-
main anonymous.
General TDi analysis
Ethylene tetraﬂuoroethylene (ETFE) and polyether ether ketone
(PEEK) tubing was obtained from Upchurch Scientiﬁc (Oak Harbor,
WA, USA) and cut to the required length to hold approximately
500 ll of liquid when full. The tubing was ﬁtted in the SensíQ Pio-
neer, connecting the injector valve to the reaction ﬂow cell. The
autosampler performed unattended loading of samples contained
in a cooled aluminum sample rack. Method programming enabled
gradient analyte injections to be performed. Routine purging rou-
tines were incorporated into each sample cycle. The system was
precleaned with 0.5% sodium hypochlorite and then coated with
0.1% Tyloxapol in water to minimize analyte interactions with
the surface of the ﬂow channels. A COOH5 sensor chip was in-
stalled in the SensíQ Pioneer system, and the system was primedwith HBS-TE. The ﬂow rate was chosen to give a low retention
time, allowing Taylor analysis to be conducted at analysis cycle
times comparable to a single FCI cycle. The viscosity of HBS was as-
sumed to be 0.94 Cp at 25 C, and a linear correction factor (CF) for
both temperature and viscosity was employed to standardize D
measurements recorded under nonstandard conditions [12] diffu-
sion coefﬁcient (Dsolvent).Bulk refractive index TDi for estimation of D
For determination of diffusion coefﬁcients, the concentration of
analyte was high enough to produce a signiﬁcant bulk refractive
index response. A series of biomolecule standards was prepared
at 10 mg ml1 in HBS-TE running buffer immediately before
priming the system into the same buffer to ensure that the bulk
refractive index difference between the injected sample and the
continuous ﬂow buffer was due entirely to the added biomolecule.
The analysis was performed for glycine (Mr = 75), alanine (Mr = 89),
b-cyclodextrin (Mr = 1135), vancomycin (Mr = 1485), polyvinyl pyr-
rolidine (Mr = 1.0  104), ribonuclease (Mr = 1.37  104), carbonic
anhydrase II (Mr = 3.0  104), ovalbumin (Mr = 4.5  104), bovine
serum albumin (Mr = 6.6  104), antibody fragment (Mr = 2.75 
104), antibody (Mr = 1.5  105), and dextran (Mr = 1.07  104,
3.7  104, 5.0  105).
In PulseTDi, a sample volume of 12 ll was loaded and injected
at 50 ll min1 followed by running buffer and allowed to migrate
through the capillary tube (tube A) before reaching the sensing re-
gions. The bulk refractive index was recorded where 1 RU was
equivalent to 1 lg ml1 analyte. The recorded bulk refractive index
response curves were ﬁtted to Eq. (1) using GraphPad Prism
(GraphPad Software, La Jolla, CA, USA). In bulk PulseTDi analysis,
C(t) was replaced by RIanalyte(t) and Cin was replaced by RImax. The
injected sample volume, volume of the tube, and D were ﬁtted lo-
cally for each curve while the remaining parameters were held
constant. For SigTDi an injection volume of approximately 1.5-fold
the capillary tube volume is required in order to produce a com-
plete sigmoidal analyte gradient proﬁle. However, rather than con-
suming such a large volume of sample we obtain equivalency
results by injecting a sample volume of 0.5-fold the tube volume
followed uninterrupted by an air bubble (approximately 2 uL)
and continuous running buffer to a ﬁnal combined volume of
approximately 1.5-fold the capillary tube volume.Curve ﬁtting
Throughout this article, parameter values are presented where
the last signiﬁcant digit is followed by parentheses containing
the standard error (SE) associated with that digit. Curve ﬁtting to
kinetic interaction curves was performed using GradFit, a custom
simulation and curve-ﬁtting package developed by BioLogic Soft-
ware (Campbell, Australia, http://www.biologic.com.au). GradFit
software uses numerical integration of the binding rate equations
to generate simulations and ﬁt interaction models to interaction
curves. A scripting interface provided a convenient model-building
environment to construct interaction models with or without a
mass transport term. Data ﬁtted in GradFit were exported into
GraphPad Prism and plotted. Qdat, a customized version of the
well-known Scrubber data analysis software from Biologic Soft-
ware, was employed for double referencing [19] of all data sets,
with the exception of the bulk refractive index-based TDi data,
which was referenced by simply subtracting the response for a
blank buffer sample. The derivative curves in Fig. 5 below (see Re-
sults and Discussion) were prepared using Microsoft Excel. The
appropriate PulseTDi or SigTDi term was included when ﬁtting
all TDi data.
Fig.2. (A) PulseTDi analysis of vancomycin. Vancomycin was diluted to 10 mg ml1
in running buffer and injected through capillary tube A at 50 ll min1 at 25 C. The
recorded bulk refractive index response did not possess a surface binding
component. The injection was repeated in quadruplicate, and curves were
superimposable. The peak (black curves) was ﬁtted (red curve) with Eq. (1), where
the geometry of the capillary tube and ﬂow rate were held constant, allowing
accurate estimation of the diffusion coefﬁcient. The volume of sample injected was
conﬁrmed by integrating the peak. In each case, the target volume of 12 ll was
attained to within 5%. The procedure was repeated for 20 different biomolecules
over anMr range of 75 to 5  105. (B) The measured diffusion coefﬁcients (Dmeasured)
were plotted against the expected diffusion coefﬁcients (Dexpected), and a regression
line was ﬁtted. (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the Web version of this article.)
Fig.3. Overlaid binding response proﬁles for the interaction of scFv with afﬁnity-
captured rhErbB2/Fc. The data acquisition rate was 8 Hz, and the SD of the residuals
for all ﬁts was less than 0.20 RU. The ﬁtted model (smooth red curves) is
superimposed on the experimental curves (rough black curves). (A) FCI analysis.
scFv was injected at 50 ll min1, in duplicate, using serial 10-fold dilutions from
1000 to 0.1 nM. (B) SigTDi analysis. scFv was injected at 50 ll min1, in triplicate,
using serial 10-fold dilutions from 1000 to 0.1 nM. A number of model-ﬁtting
variations were evaluated, and the results are given in Table 1. A simple ‘‘rapid
mixing’’ model with ﬁtted parameters ka, kd, Rmax, and D is shown.
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For the standard FCI format, a sensing chip with a carboxylated
dextran-based hydrogel (COOHV) was installed and the biosensor
was primed into HBS-TE buffer. Protein G was immobilized onto
two sensing channels by standard amine coupling to a mass equiv-
alent to 1200 RU. Each binding interaction cycle was performed as
follows. The fusion protein, rhErbB2/Fc, was diluted to 10 nM in
running buffer and captured onto the ﬁrst channel by injecting
50 ll at 25 ll min1, whereas the second channel was left un-
coated and used for double referencing of the data set. scFv diluted
in running buffer was then injected over both channels at
50 ll min1, and dissociation was observed for 10 min. The surface
was regenerated with a 60-s exposure of both channels to 20 mM
NaOH. This series of three injections was repeated for each cycle.
For SigTDi, the experiments were performed as described for FCI
with the following differences. Here, 250 ll of analyte sample was
injected at 30 ll min–1 through the capillary tube (tube B) prior to
contacting the sensing surface. The residence time (s) is equal to
the injected sample volume divided by the ﬂow rate, and the full
sample contact time must exceed s in order for the gradient to ex-
ceed the maximum analyte concentration. Therefore, the contact
time was chosen such that the total volume injected approached
1.5-fold the capillary volume. Both FCI and TDi assays wereperformed during the same assay run, over the same sensing sur-
faces, and using the same reagent preparations in order to mini-
mize experimental variability and enable accurate comparison of
the techniques.
Analysis of furosemide–carbonic anhydrase II interactions
Carbonic anhydrase II was immobilized onto a sensing surface
by amine coupling. A second sensing surface remained uncoated
to provide an accurate reference surface. A mass equivalent to
approximately 4500 RU of carbonic anhydrase II was immobilized.
Furosemide binding was tested at 25 C by dissolving the drug di-
rectly in HBS-T to 1 mM and then making dilutions of this stock
concentration as required. EDTA was excluded from the buffer to
maintain the binding activity of the Zn-dependent carbonic anhy-
drase II. TDi analysis was performed at a ﬂow rate of 100 ll min1
using capillary tube C. A complex binding data set was recorded by
allowing the carbonic anhydrase II-coated surface to degrade at
25 C for 4 days before performing a SigTDi analysis. All TDi injec-
tions contained 250 ll of analyte sample.
Afﬁnity ranking
HSA was immobilized by standard amine coupling onto a
COOH5 chip surface, giving a loaded mass equivalent to 10 kRU
where 1 RU = 1 response units = 1  106 refractive index units
and represents a surface mass loading of 1 pg mm2. Warfarin
was prepared as 33-mM stocks in DMSO and then diluted to the
neat working concentration in HBS-TE with a ﬁnal DMSO
Fig.5. Time progression series of overlaid SigTDi binding response curves for a
warfarin–HSA interaction. Here, 250 ll of 3 mM warfarin was injected by TDi over
amine-coupled HSA for 15 replicates at 15-min intervals. Inset: Derivative of the
ﬁrst seven binding curves after a 5-point smoothing. Data were recorded at 8 Hz for
enhanced resolution of the derivative curve. The derivative curves contain three or
more distinct peaks associated with different binding site populations and indicated
by the vertical broken lines and Roman numerals.
Fig.4. Furosemide–carbonic anhydrase II binding response curves. Each injected
concentration was performed in duplicate. (A) FCI analysis. Carbonic anhydrase II
was immobilized by amine coupling, and serial 3-fold dilutions of furosemide from
0.46 to 111 lM were injected at 50 ll min1. A global ﬁt of a simple 1:1 kinetic
interaction model was applied (smooth red curves). (B) SigTDi analysis. Carbonic
anhydrase II was immobilized by amine coupling, and four serial 10-fold dilutions
of furosemide from 1 lM to 1 mM were injected by TDi at 100 ll min1. A global ﬁt
of a simple 1:1 kinetic interaction model was applied (smooth red curves). (C)
SigTDi analysis. A carbonic anhydrase II-coated surface was permitted to degrade
over several days at 25 C. Serial 3-fold dilutions were injected from 12 lM to 1 mM
at 50 ll min1 by TDi. The analysis was performed at 10 C to preserve weak
nonspeciﬁc binding in order to mimic a realistic complex data set. A 2:1 simple
interaction model was ﬁtted globally (smooth red curves) where only Rmax2 was
allowed local values. Returned parameter values are shown with the SE associated
with the last digit in parentheses. (For interpretation of the references to color in
this ﬁgure legend, the reader is referred to the Web version of this article.)
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100 ll min1 through capillary tube A for a contact time of 390 s.Real-time isotherm
HSA was immobilized by standard amine coupling onto a
COOHV chip surface, giving a loaded mass equivalent to 4.5 kRU.
The surface was allowed to stabilize for 24 h in order to limit con-
formational shifting of HSA. Warfarin was prepared as a 33-mM
stock in DMSO and then diluted to 1 mM, the neat working concen-
tration, in HBS-TE with a ﬁnal DMSO concentration of 3%. For
PulseTDi, 5 ll of sample was injected at 25 ll min–1 into capillary
tube D and the injection was terminated after 158 s. This injection
was repeated for a series of 12 serial 2-fold dilutions in triplicate.
Data were double referenced in Qdat before model ﬁtting. For Sig-
TDi, 60 ll of 1 mMwarfarin was injected at 10 ll min1 and termi-
nated after 1040 s. Regeneration was not necessary because
warfarin dissociated rapidly from the HSA-coated surface. The buf-
fers contained approximately 3% DMSO, and the resulting bulkrefractive index offsets were eliminated by conventional double
referencing. The presence of DMSO offsets also causes a non-negli-
gible offset in sensitivity between sensing channels that is related
to an excluded volume effect. The sensing channels were normal-
ized using bulk refractive index standards to compensate for this
effect.
Results and discussion
Bulk refractive index TDi
A series of biomolecules over a wide molecular weight range
(Mr = 75 to 5  105) were analyzed using bulk refractive index
PulseTDi analysis. The resulting PulseTDi curves were ﬁtted with
Eq. (1) (where C(t) and Ci were replaced by RIanalyte(t) and RImax,
respectively) for estimation of diffusion coefﬁcients. A set of four
superimposed curves for vancomycin are shown in Fig. 2 with the
model ﬁtted. The diffusion coefﬁcients for a set of biomolecules
were determined by this method, and the measured diffusion coef-
ﬁcients (Dmeasured) were compared with the literature values (Dex-
pected) [12], giving a correlation coefﬁcient of 0.995. In addition,
the linear regression analysis gave R2 = 0.999. This agreement be-
tween the TDi curves and theory validates the application of the
Taylor dispersionmodel. The determination of diffusion coefﬁcients
by solution-phase Taylor dispersionmethods is well known [9], but
its use in biosensing provides new possibilities of practical value in
routine applications. In particular, D can also be determined as a ﬁt-
ted parameter from the solid-phase binding interaction curves,
reducing the amount of analyte sample required and allowing crude
analyte samples to be used. Measurement of the diffusion coefﬁ-
cient by either the solution- or solid-phase TDi methods is particu-
larly valuable in conﬁrming the absence of analyte aggregates.
Antibody fragment–receptor interaction
The interaction of scFv with ErbB2-Fc bound to a sensing sur-
face was analyzed by both FCI and TDi, giving the response curves
Table 1
Parameter values returned for global ﬁtting of the simple ‘‘rapid mixing’’ model and the two-compartment model.
Model type ka
(M1 s1)
kd
(s1)
Rmax
(RU)
D
(m2 s–1)
km
(RU M1 s1)
Concentration
(M)
Simple 7.094(3)  105 7.20(2)  105 34.597(7) Fixed – Fixed
Simple 6.398(1)  105 6.87(2)  105 35.018(2) 8.878(2)  1011 – Fixed
Simple 6.5(2)  105 6.91(2)  105 35.012(2) Fixed – 1.01 lM
Two-compartment 7.15(1)  106 8.90(4)  105 34.531(4) Fixed 1.0(1)  109 Fixed
Two-compartment 6.592(2)  105 6.94(2)  105 35.007(2) 8.859(2)  1011 Linked to D Fixed
Two-compartment 6.517(3)  105 6.92(1)  105 35.012(2) 8.864(1)  1011 6.9(2)  108 Fixed
Note. The data from Fig. 3 were ﬁtted with a number of interaction models. Parameters that were constrained to known best ﬁt values are indicated by ‘‘Fixed.’’ km is by
deﬁnition absent from the Simple model since mass transport of analyte is assumed to be inﬁnitely fast. By representing km using Eq. (9) and coupling the ﬁtted parameter D
to this expression, it was possible to link the estimation of km to estimates of D, as indicated by ‘‘Linked to D.’’ The number in parentheses for each parameter value is the SE of
the last signiﬁcant digit.
Table 2
ka Values returned from local ﬁtting of TDi curves and FCI curves and relative error with respect to the global parameter values.
nM FCI TDi
ka (M1 s1)  105 % Relative error ka (M1 s1)  105 % Relative error
10 8.29(3) 16.86 6.03(1) 5.23
10 6.80(1) 4.14 6.42(1) 0.90
10 – – 6.30(1) 0.99
100 4.59(2) 35.30 6.277(5) 1.35
100 5.74(3) 19.09 6.426(5) 0.99
100 – – 6.358(5) 0.08
1000 6.62(1) 6.68 5.899(6) 7.28
1000 8.04(3) 13.34 5.946(6) 6.65
1000 – – 5.883(6) 5.23
Note. The data from Fig. 3 were ﬁtted with the simple model where ka, kd, Rmax, and Dwere ﬁtted locally to each curve. km was constrained to a constant value. The average SD
of the residuals for each local ﬁt was less than 0.2 RU.
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interaction model to FCI data gave kinetic constants that were
comparable (<15% variation in any ﬁtted parameter) to those from
the TDi model ﬁt, and the average standard deviation (SD) of the
residuals was low (0.2 RU) for both data sets. All replicates were
superimposable, and TDi data were comparable in quality to FCI
data. The absence of any systematic deviation of the ﬁtted model
over such a wide concentration range (four orders of magnitude)
implies that the TDi concentration proﬁle conforms to model pre-
dictions even at high dilution factors. The ﬁtted TDi model re-
turned D = 8.878(2)  1011 m2 s1 for the scFv analyte, which
was within 5% of the expected value [20]. In addition, the ﬁtted
km from TDi was in excellent agreement with km calculated from
theory, whereas km from FCI was 50% higher. Therefore, TDi re-
turned accurate estimates of km, and the correspondence with the-
ory implies that the dextran hydrogel did not contribute
signiﬁcantly to MTL given that this source of MTL is not accounted
for in the theory. In general, the TDi method provided higher con-
ﬁdence in the measured parameters, as indicated by lower SEs in
estimated parameters.
A particularly useful beneﬁt of TDi is apparent when the data in
Fig. 3 are ﬁtted locally. Local model ﬁtting to a single binding curve
far from the Rmax is known to return unreliable results [21]; there-
fore, such curves were omitted. The difference between TDi and FCI
largely concerns determination of ka, with no signiﬁcant change in
determination of kd. Fortunately, kd can be established accurately
for single curves that approach Rmax, a condition that is usually
not difﬁcult to achieve. Table 2 shows ka values returned from local
ﬁtting to both data sets and the relative error with respect to the
global parameter values. TDi outperformed FCI dramatically, giving
a 5-fold lower maximum relative error. The SE returned for each
parameter was also signiﬁcantly lower for TDi, giving estimates
that were lower than those from a global ﬁt to FCI data. The esti-
mates of D returned from local ﬁtting were extremely precise, giv-
ing a coefﬁcient of variation (CV) of only 0.5%, and the mean for theset of local ﬁts was within 3% of the global value. Therefore, the
data strongly suggest that a local ﬁt to a single TDi curve provides
kinetic constants that are as robust as those from global ﬁtting to a
set of standard FCI curves. The data also demonstrate the value of
global model ﬁtting when using standard FCI data.
TDi and mass transport limitation
When characterizing PEGylated antibody fragments, Kubetzko
and coworkers [22] determined the active concentration and ki-
netic interaction constants from separate assays, and dynamic light
scattering provided accurate Mr. TDi can potentially perform all
three measurements. For example, values of D recovered from a
ﬁt of an interaction model to TDi data can be used to estimate Mr
from empirical correlations [12], obviating the need for a pure ana-
lyte sample at high concentrations as required in techniques such
as dynamic light scattering. Experimental conditions can be chosen
such that sufﬁcient MTL is present for estimation of the active ana-
lyte concentration while also estimating kinetic interaction con-
stants and D from the ﬁtted model. The data in Fig. 3 were
recorded on a low MTL surface, and (intuitively) analysis of these
data would not be expected to provide accurate estimation of
parameters that depend on MTL such as active concentration. Sur-
prisingly, it was possible to obtain good estimates for ka, kd, D, km,
and active concentration from this data set. The degree of MTL can
be estimated as follows: %MTL = 100  (ka  Rmax)/[(ka  Rmax) + km],
giving a value of 3.1% for the TDi data in Fig. 3. It is known that an
accurate estimate of km, and therefore D, is necessary for the deter-
mination of the active analyte concentration under conditions of
partial MTL [15,16]. Given that an accurate estimate of km was re-
turned from the experimental data, it was posited that the active
concentration might be returned from ﬁtting a two-compartment
model.
Eq. (9) was substituted for km, and the TDi data in Fig. 3B were
reﬁtted solving for global values of ka, kd, D, and analyte
Fig.6. Afﬁnity analyses of warfarin–HSA interaction. (A) Serial 2-fold dilutions of warfarin from 0.244 nM to 1 mMwere prepared. Here, 5 ll of each was injected by PulseTDi
at 25 ll min1. The superimposed double referenced response curves recorded over a noncoated sensing surface are shown for all injections. (B) Same as analysis in panel A,
but the speciﬁc binding response was isolated by application of double referencing to the response curves recorded over the HSA-coated sensing surface. (C) The speciﬁc
binding response curves for 1 mM warfarin were replotted together with the expected relative analyte concentration proﬁle calculated from Eq. (1). (D) A selection of the
response points from the curves in panel C were plotted with respect to the expected warfarin concentration, and a two-site steady-state afﬁnity model was ﬁtted using Qdat.
(E) The analysis was repeated using SigTDi and a larger capillary (tube E). Here, 60 ll of 1 mMwarfarin was injected by SigTDi, producing a sigmoidal dispersion. The expected
relative dispersion proﬁle is the sigmoidal (smooth red curve) curve that is shifted to the right of the experimental binding response curve (rough black curve). A three-site
real-time isotherm model (Eq. (12)) was ﬁtted using GraphPad Prism, and the ﬁtted parameters for the two speciﬁc binding sites of interest are shown on the plot as 95%
conﬁdence limits. The ﬁtted isotherm (smooth red curve) superimposes onto the experimental isotherm, giving an average residual SD of 0.26 RU. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the Web version of this article.)
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global value by representing the concentrations as follows: neat,
neat  0.1, neat  0.01, neat  0.001, and neat  0.0001. In practice,the analyte concentration is usually known to within 2-fold of the
initial estimated value, and constraining its value within this limit
ensured convergence of the model. When solving for analyte
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and 6.9  108 RU M1 s1, respectively. The initial values for the ﬁt-
tedparameterswere chosenwithahighdisparitywith respect to the
expected parameter estimates in order to provide a more realistic
test of the model ﬁt. Therefore, the initial parameter values were
chosen as Rmax = 40 RU, ka = 5  104 M1 s1, kd = 1  103 s1, and
analyte concentration = 5  106 M.
Despite the low level of MTL, the analysis returned an accurate
analyte concentration in addition to parameter values almost
identical to those in Fig. 3. The returned parameters were
Rmax = 35.012(2) RU, ka = 6.5(2)  105 M1 s1, kd = 6.91(2)  105
s1, and analyte concentration = 1.01(3)  106 M. The analyte
concentration was expected to be 1 lM because the km employed
in this ﬁt was obtained from a previous ﬁt where the concentration
was assumed to be exactly 1 lM. An insigniﬁcant change in active
concentration was observed when the analysis was repeated using
the expected km (6.82  108 RU M1 s1). While mindful of the risk
of overinterpreting the results, the accuracy and SE of the returned
analyte concentration were remarkable, whereas ka remained
accurate, albeit with an increased SE.
Furosemide–carbonic anhydrase II interactions
Furosemide is a carbonic anhydrase inhibitor with anMr of 336.
Its diffusion coefﬁcient is expected to be 5.33  1010 m2 s1 from
the Stokes–Einstein–Sutherland equation [11]. Kinetic analysis of
furosemide binding to immobilized carbonic anhydrase II is shown
in Fig. 4. A series of serial 2-fold dilutions was analyzed in triplicate
by FCI, and the data were globally ﬁtted with a 1:1 interaction
model, as shown in Fig. 4A. As expected, the model interaction
was well described by the simple model. The analysis was repeated
by TDi using serial 10-fold dilutions, and the results for a ﬁt to a
global 1:1 interaction model are shown in Fig. 4B. Replicate TDi
curves showed high reproducibility at each injected concentration,
and the kinetic constants were comparable to those from FCI anal-
ysis. The TDi curves covered a concentration range of 1000-fold,
whereas FCI curves covered a much lower range of 252-fold. The
FCI concentrations approximate the limits that produce sufﬁcient
curvature for reliable kinetic analysis. Therefore, concentrations
outside this range provide little kinetic information. In contrast,
TDi curves provide adequate kinetic curvature over a wider range,
being effectively unbounded at higher concentrations. The ﬁtted
parameter, D, was practically identical to the predicted value, indi-
cating that the analyte was not aggregated. Both TDi and FCI gave
reasonable SDs of the residuals for each global ﬁt. Interestingly, the
SE associated with ﬁtting ka to TDi data was 20-fold lower than
that from FCI data, indicating higher conﬁdence in TDi analysis.
Multisite furosemide–carbonic anhydrase II binding
To investigate resolution of two-site binding by TDi, a carbonic
anhydrase II-coated sensing surface was allowed to degrade and
binding of furosemide was recorded at 10 C, as shown in Fig. 4C.
Nonspeciﬁc binding became signiﬁcant at higher analyte concen-
trations, presumably because the degraded carbonic anhydrase II
presented more hydrophobic pockets than the native form of the
protein. Visual inspection of the data from the degraded carbonic
anhydrase II surface revealed that speciﬁc analyte binding oc-
curred earlier for the higher afﬁnity site, enabling the curve-ﬁtting
algorithm to readily distinguish both components. A global ﬁt of a
two-site interaction model to the TDi data resolved the kinetic con-
stants for the speciﬁc afﬁnity site in the presence of a larger re-
sponse from the nonspeciﬁc binding site while also returning D.
Low variation (CV = 3.6%) in ka between curves was observed when
each curve was ﬁtted separately (i.e., locally), indicating that a sin-
gle curve provided a reliable estimate of the kinetic constants.More signiﬁcant, nonspeciﬁc binding comprising approximately
70% of the total binding response did not interfere signiﬁcantly
with estimation of the kinetic constants from single TDi curves.
The value of D obtained from the two-site ﬁt was within 10% of
the expected value after correction for a temperature offset of
15 C, suggesting that analyte aggregation at the lower analysis
temperature was not signiﬁcant.
Afﬁnity ranking
In some applications, it is not appropriate to ﬁt a kinetic model,
and a simple means of providing a kinetic/afﬁnity ranking can suf-
ﬁce. For example, many proteins degrade rapidly or shift between
different conformational states [23,24], and if these changes occur
while a kinetic/afﬁnity analysis is being performed, the recorded
data represent the average kinetic/afﬁnity state during the assay.
Changes in binding properties that occur within minutes can be
monitored using the TDi approach, providing a detailed account
of the changing binding characteristics. Using warfarin–HSA as a
model, it was possible to track changes in the afﬁnity for a two-site
interaction while the HSA was in transition between different con-
formations. Therefore, the overlaid binding response curves in
Fig. 5 effectively represent a time-series progression where dy-
namic changes in afﬁnity can be qualitatively compared. Three or
more binding rate peaks are visible in the derivative plot in Fig. 5
(inset plot), and the progression of these binding sites toward low-
er afﬁnity (i.e., shift to right) is evident.
Real-time isotherm
TDi may provide a rapid method for afﬁnity determination of
compounds in label-free screening. The model interaction of war-
farin with HSA is characteristic of fragment screen interactions,
where both theMr and afﬁnity are low, and was employed to dem-
onstrate the real-time isotherm technique. Typically, the approach
to steady state is almost instantaneous when the afﬁnity is low and
the kinetic constants are relatively fast. Under these conditions, the
TDi binding response curve can be treated as a real-time afﬁnity
isotherm. Both PulseTDi and SigTDi analyses produced equivalent
results, as shown in Fig. 6. The effectiveness of double referencing
is evident in Fig. 6A given the absence of any response over a con-
trol sensing surface. Therefore, we may assume that all interfer-
ences have been accurately subtracted from the warfarin–HSA
curves in Fig. 6B. PulseTDi was repeated for a series of warfarin
concentrations in order to demonstrate the reproducibility of the
technique. Each concentration was repeated in triplicate and pro-
duced binding curves that were essentially superimposable with
the exception of 1 partially outlying curve from a set of 36. The
binding curves for 1 mM warfarin are shown separately in Fig. 6C
along with the expected analyte dispersion proﬁle calculated from
Eq. (1), where D was calculated from the Stokes–Einstein–Suther-
land equation [11]. A subset of response points were selected from
these curves and plotted against the expected concentration. A
two-site afﬁnity model was ﬁtted to this isotherm, as shown in
Fig. 6D. The resulting afﬁnity constants were in good agreement
with literature values [5,6] and were also in good agreement with
a replicate analysis performed by SigTDi (Fig. 6E). Eq. (12) was di-
rectly ﬁtted to the SigTDi isotherm, which, in contrast to a standard
isotherm plot (i.e. Req vs. concentration), enables D to be ﬁtted. The
95% conﬁdence limits for each returned parameter indicated that
both high-afﬁnity and low-afﬁnity sites are well determined from
a single TDi curve. However, when run times are less critical, it is
advisable to include another SigTDi curve at a 10-fold lower con-
centration , or alternatively at the same concentration but at a dif-
ferent injection ﬂow rate, to further improve the parameter
conﬁdence intervals. This also improves resistance to occasional
410 Evaluation of Taylor dispersion injections / J.G. Quinn / Anal. Biochem. 421 (2012) 401–410interferences that do not subtract exactly on double referencing.
Other more complex binding models might beneﬁt from applica-
tion of TDi, but these are beyond the scope of the current article.Conclusion
TDi forms highly ordered analyte gradients, without added cost
in terms of complexity or expense, for enhanced resolution of both
simple and complex biomolecular binding interactions. TDi en-
abled high-quality kinetic analysis over a broad Mr range, giving
reliable estimates of the analyte diffusion coefﬁcients in addition
to the kinetic interaction constants. Kinetic analyses of single TDi
curves were shown to provide parameter estimates that were as
reliable as those from a global model ﬁt to multiple standard injec-
tion curves. The presence of nonspeciﬁc binding comprising as
much as 70% of the recorded binding response did not prevent res-
olution of the high-afﬁnity interaction constants from single TDi
curves. TDi provided reliable estimates of ka, kd, Rmax, D, and active
analyte concentration from a single set of binding interaction
curves. A real-time isotherm that provided unprecedented resolu-
tion of multisite interactions was demonstrated and may be of par-
ticular interest in compound screening applications. Sample
preparation, assay setup, and method programming were simpli-
ﬁed in comparison with the standard approach. In conclusion,
enhanced biophysical characterization was possible while reduc-
ing assay complexity and run time.
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